NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,000 | 0.0% | 18,200 | -12.1% | 0.00% | – |
Q3 2020 | $11,000 | -57.7% | 20,705 | -39.6% | 0.00% | – |
Q1 2020 | $26,000 | +30.0% | 34,271 | +116.3% | 0.00% | – |
Q2 2019 | $20,000 | -86.8% | 15,845 | -72.7% | 0.00% | – |
Q1 2019 | $152,000 | +90.0% | 58,112 | +20.5% | 0.00% | – |
Q4 2018 | $80,000 | -82.1% | 48,234 | -47.7% | 0.00% | – |
Q3 2018 | $448,000 | +60.6% | 92,206 | +107.2% | 0.00% | – |
Q2 2018 | $279,000 | +156.0% | 44,498 | +314.7% | 0.00% | – |
Q4 2017 | $109,000 | -82.3% | 10,730 | -84.1% | 0.00% | – |
Q3 2017 | $617,000 | +65.0% | 67,442 | +158.5% | 0.00% | – |
Q4 2015 | $374,000 | – | 26,087 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|